2.Revision of threshold levels for evoking pollinosis to oak, pine, Japanese hop, and ragweed in the metropolitan area Seoul, Korea
Young-Jin CHOI ; Ju-Hee JEON ; Jin Hyeok JEONG ; Kyu-Rang KIM ; Yung-Seop LEE ; Jae-Won OH
Allergy, Asthma & Respiratory Disease 2020;8(4):199-205
Purpose:
The threshold levels for symptom development of pollinosis vary among studies and countries. This study aimed to determine currently used threshold levels for it.
Methods:
Oak, pine, Japanese hop, and ragweed pollen samples were collected daily for 8 years from the Seoul and Guri areas. A total of 792 subjects with allergy to these pollens were recruited. The symptom index (SI) was assessed through telephone interviews and allergy questionnaires, and data were analyzed using decision tree.
Results:
The risk index for oak pollen allergy was “mild” when the pollen count was 0–2 grains/m3 , “moderate” when it was 3–11 grains/m3 , “severe” when it was 12–28 grains/m3 , and “dangerous” when it was ≥ 29 grains/m3 . The risk level for pine pollen allergy was “mild” when the pollen count was 0–4 grains/m 3 , “moderate” when it was 5–42 grains/m3 , “severe” when it was 43–66 grains/m3 , and “dangerous” when it was ≥ 67 grains/m3 . For Japanese hop pollen allergy, the risk level was “mild” when the pollen count was 0–8 grains/m3 , “moderate” when it was 9–10 grains/m3 , “severe” when it was 11–19 grains/m3 , and “dangerous” when it was ≥ 20 grains/m3 . Finally, for ragweed, the risk level was “mild” when the pollen count was 0–1 grains/m3 , “moderate” when it was 2–6 grains/m3 , “severe” when it was 7–33 grains/m3 , and “dangerous” when it was ≥ 34 grains/m3 .
Conclusions
Revising the threshold levels for the risk index for pollen allergies may be useful for developing pollen prediction models for patients with pollen allergies in Korea.
3.Clinical Characteristics of COVID-19: Clinical Dynamics of Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection Detected by Early Active Surveillance
Hyeon Jeong SUH ; Deok Hee KIM ; Eun Young HEO ; Hyun Woo LEE ; Jung-Kyu LEE ; Chang-Seop LEE ; Mijeong KIM ; Yong Duk JEON ; Jin-Won CHUNG ; Young Keun KIM ; Pyo Jin SHIN ; Mi Suk LEE ; Jin Suk KANG ; Myung Jin LEE ; Baek-Nam KIM ; Sang-Won PARK
Journal of Korean Medical Science 2020;35(32):e297-
Background:
There is limited information describing the presenting characteristics and dynamic clinical changes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosed in the early phase of illness. This study is a case series of patients with coronavirus disease 2019 (COVID-19) admitted to 11 hospitals in Korea.
Methods:
Patients with confirmed SARS-CoV-2 infection by positive polymerase chain reaction (PCR) testing of respiratory specimens by active surveillance that were finally discharged between February 20 and April 30, 2020 were included. Patients were classified into mild and non-mild groups on initial admission according to oxygen demand and Sequential Organ Failure Assessment score, and the mild group was followed up and subgrouped into non-aggravation and aggravation groups.
Results:
A total of 161 patients with SARS-CoV2 infection were enrolled. Among the mild group of 136 patients, 11.7% of patients experienced clinical aggravation during hospitalization, but there was no initial clinical parameter on admission predicting their aggravation. Fever (odds ratio [OR], 4.56), thrombocytopenia (OR, 12.87), fever (OR, 27.22) and lactate dehydrogenase (LDH) > 300 U/L (OR, 18.35), and CRP > 1 mg/dL (OR, 11.31) significantly indicated aggravation in the 1st, 2nd, 3rd, and 4th 5-day periods, respectively.PCR positivity lasted for a median of 22 days and 32 days after the onset of illness in the nonaggravation and aggravation groups, respectively.
Conclusion
Old age was associated with early severe presentation. Clinical aggravation among asymptomatic or mild patients could not be predicted initially but was heralded by fever and several laboratory markers during the clinical course.
4.A Comparative Study of Tensile Strength of Three Operative Fixation Techniques for Metacarpal Shaft Fractures in Adults: A Cadaver Study
Jin Rok OH ; Doo Sup KIM ; Jun Seop YEOM ; Sang Kyu KANG ; Yun Tae KIM
Clinics in Orthopedic Surgery 2019;11(1):120-125
BACKGROUND: We sought to estimate the ultimate tensile strength after metacarpal shaft fracture repair in adults using three operative fixation methods: plate fixation, Kirschner wire (K-wire) fixation, and intramedullary headless compression screw fixation. We also compared the advantages and disadvantages of each operative technique. METHODS: We acquired 30 metacarpal bones from four Korean adult cadavers without trauma, operative history, or deformities. The 30 metacarpal bones were divided into ten groups consisting of three metacarpal bones each with matching sizes and lengths. They were fractured, reduced, and fixed with plate and screws, K-wires, or headless compression screws. We performed force testing, collected ultimate tensile strength data, and created a stress-strain graph. RESULTS: The ultimate tensile strength of ten groups according to the fixation method was as follows: late and screw fixation, 246.1 N (range, 175.3 to 452.4 N); K-wire fixation, 134.6 N (62.7 to 175.0 N); and intramedullary headless compression screw fixation, 181.2 N (119.2 to 211.7 N). The median tensile strength of each fixation method was significantly different. In addition, the post-hoc test showed significant difference between the plate and screw fixation and K-wire fixation, between the headless compression screw fixation and K-wire fixation, and between the headless compression screw fixation and plate and screw fixation. CONCLUSIONS: The tensile strength median values decreased in the following order showing significant differences among the fixation methods: plate and screw fixation, headless compression screw fixation, K-wire fixation. Significant differences were also observed between the plate and screw fixation and K-wire fixation, between the headless compression screw fixation and K-wire fixation, and between the headless compression screw fixation and plate and screw fixation.
Adult
;
Cadaver
;
Congenital Abnormalities
;
Humans
;
Metacarpal Bones
;
Methods
;
Tensile Strength
5.Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients.
Hyery KIM ; Hyoung Jin KANG ; Kyung Duk PARK ; Kyung Nam KOH ; Ho Joon IM ; Jong Jin SEO ; Jae Wook LEE ; Nack Gyun CHUNG ; Bin CHO ; Hack Ki KIM ; Jae Min LEE ; Jeong Ok HAH ; Jun Ah LEE ; Young Ho LEE ; Sang Kyu PARK ; Hee Jo BAEK ; Hoon KOOK ; Ji Yoon KIM ; Heung Sik KIM ; Hwang Min KIM ; Hee Won CHUEH ; Meerim PARK ; Hoi Soo YOON ; Mee Jeong LEE ; Hyoung Soo CHOI ; Hyo Seop AHN ; Yoshifumi KAWANO ; Ji Won PARK ; Seokyung HAHN ; Hee Young SHIN
Cancer Research and Treatment 2019;51(1):357-367
PURPOSE: Dexrazoxane has been used as an effective cardioprotector against anthracycline cardiotoxicity. This study intended to analyze cardioprotective efficacy and secondary malignancy development, and elucidate risk factors for secondary malignancies in dexrazoxane-treated pediatric patients. MATERIALS AND METHODS: Data was collected from 15 hospitals in Korea. Patients who received any anthracyclines, and completed treatment without stem cell transplantation were included. For efficacy evaluation, the incidence of cardiac events and cardiac event-free survival rates were compared. Data about risk factors of secondary malignancies were collected. RESULTS: Data of total 1,453 cases were analyzed; dexrazoxane with every anthracyclines group (D group, 1,035 patients) and no dexrazoxane group (non-D group, 418 patients). Incidence of the reported cardiac events was not statistically different between two groups; however, the cardiac event-free survival rate of patients with more than 400 mg/m2 of anthracyclines was significantly higher in D group (91.2% vs. 80.1%, p=0.04). The 6-year cumulative incidence of secondary malignancy was not different between both groups after considering follow-up duration difference (non-D, 0.52%±0.37%; D, 0.60%±0.28%; p=0.55). The most influential risk factor for secondary malignancy was the duration of anthracycline administration according to multivariate analysis. CONCLUSION: Dexrazoxane had an efficacy in lowering cardiac event-free survival rates in patients with higher cumulative anthracyclines. As a result of multivariate analysis for assessing risk factors of secondary malignancy, the occurrence of secondary malignancy was not related to dexrazoxane administration.
Anthracyclines
;
Cardiotoxicity
;
Dexrazoxane
;
Disease-Free Survival
;
Follow-Up Studies
;
Humans
;
Incidence
;
Korea
;
Multivariate Analysis
;
Neoplasms, Second Primary
;
Risk Factors*
;
Stem Cell Transplantation
6.Quality of information on the Internet for Korean patients with inflammatory bowel disease
Jun Sik YOON ; Sang Jik LEE ; Eun Soo KIM ; Sung Kook KIM ; Min Kyu JUNG ; Hyun Seok LEE ; Yong Hwan KWON ; Su Youn NAM ; Seong Woo JEON ; Sun JIN ; Joon Seop LEE ; Seong Jae YEO
The Korean Journal of Internal Medicine 2019;34(6):1215-1222
BACKGROUND/AIMS:
The Internet is the main resource for health-related information. The incidence of inflammatory bowel disease (IBD) is rapidly increasing in Asian countries. However, the quality of websites for IBD available in this region has not been evaluated. We aimed to evaluate the quality of the information on IBD obtained from Korean websites.
METHODS:
Using the terms “Crohn’s disease†or “ulcerative colitis,†websites were selected from those obtained with the three most renowned search engines in Korea; 60 websites from the results of each engine were chosen. The websites were classified into institutional, commercial, charitable, supportive, or alternative medicine types according to the characteristics of each site. The websites were evaluated regarding content quality using the validated DISCERN instrument and the Journal of the American Medical Association benchmarks.
RESULTS:
The median score of all the websites according to the DISCERN instrument was 32 (interquartile range, 25 to 47) out of 80, indicating an insufficient overall quality of information. The alternative medicine sites scored the lowest, whereas the institutional sites scored the highest (p < 0.05). The quality of information was significantly different among the search engines (p = 0.028). The rank of appearance in the Google search result did not correlate with the quality level of the information.
CONCLUSIONS
The quality of information on the Internet regarding IBD varied according to the website type and search engine. Accreditation and quality assurance systems should be implemented for websites to ensure that the public and patients obtain accurate information on IBD.
7.An Unexpected Adverse Event during Colonoscopy Screening: Bochdalek Hernia.
Joon Seop LEE ; Eun Soo KIM ; Min Kyu JUNG ; Sung Kook KIM ; Sun JIN ; Deok Heon LEE ; Jun Won SEO
The Korean Journal of Gastroenterology 2018;71(5):290-293
Bochdalek hernia (BH) is defined as herniated abdominal contents appearing throughout the posterolateral segment of the diaphragm. It is usually observed during the prenatal or newborn period. Here, we report a case of an adult patient with herniated omentum and colon due to BH that was discovered during a colonoscopy. A 41-year-old woman was referred to our hospital with severe left chest and abdominal pain that began during a colonoscopy. Her chest radiography showed colonic shadow filling in the lower half of the left thoracic cavity. A computed tomography scan revealed an approximately 6-cm-sized left posterolateral diaphragmatic defect and a herniated omentum in the colon. The patient underwent thoracoscopic surgery, during which, the diaphragmatic defect was closed and herniated omentum was repaired. The patient was discharged without further complications. To the best of our knowledge, this case is the first report of BH in an adult found during a routine colonoscopy screening.
Abdominal Pain
;
Adult
;
Colon
;
Colonoscopy*
;
Diaphragm
;
Female
;
Hernia*
;
Hernia, Diaphragmatic
;
Humans
;
Infant, Newborn
;
Mass Screening*
;
Omentum
;
Radiography
;
Thoracic Cavity
;
Thoracoscopy
;
Thorax
8.Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial.
Hyuk YOON ; Dong Ho LEE ; Yong Hyun LEE ; Ju Cheol JEONG ; Soo Teik LEE ; Myung Gyu CHOI ; Seong Woo JEON ; Ki Nam SHIM ; Gwang Ho BAIK ; Jae Gyu KIM ; Jeong Seop MOON ; In Kyung SUNG ; Sang Kil LEE ; Poong Lyul RHEE ; Hwoon Yong JUNG ; Bong Eun LEE ; Hyun Soo KIM ; Sang Gyun KIM ; Kee Myung LEE ; Jae Kyu SEONG ; Jin Seok JANG ; Jong Jae PARK
Gut and Liver 2018;12(5):516-522
BACKGROUND/AIMS: To evaluate the efficacy and safety of a controlled release, once-daily formulation of mosapride (UI05MSP015CT) in patients with functional dyspepsia (FD). METHODS: Patients with FD were randomly assigned (1:1) to receive either UI05MSP015CT (15 mg once a day, study group) or mosapride (5 mg three times a day, control group) and corresponding placebo for 4 weeks. The primary endpoint was a change in the gastrointestinal symptom score (GIS) evaluated at enrollment and after 4 weeks. Secondary endpoints were changes in the Nepean Dyspepsia Index-Korean version (NDI-K), rate of satisfactory symptom relief, and rate of adverse events. RESULTS: A total of 138 patients were enrolled (female, 73.9%; mean age, 44.0±15.4 years). After excluding patients who violated the study protocol, 59 and 58 patients from the study and control groups, respectively, were included in the per-protocol analysis. No difference was observed in drug compliance between the control and study groups (97.07%±4.52% vs 96.85%±6.05%, p=0.870). Changes in GIS scores were 9.69±6.44 and 10.01±5.92 in the study and control groups. The mean difference in GIS change between groups was 0.33 (95% confidence interval, 1.75 to 2.41), demonstrating non-inferiority of UI-05MSP015CT (p=0.755). The rate of satisfactory symptom relief was not different between the study and control groups (39.0% vs 56.9%, p=0.053). No differences in change in NDI-K score (14.3 vs 16.9, p=0.263) or rates of adverse events (12.9% vs. 4.4%, p=0.062) were observed between the study and control groups. CONCLUSIONS: Once-daily mosapride is not inferior to conventional mosapride in efficacy and is safe in patients with FD.
Compliance
;
Dyspepsia*
;
Humans
9.Molecular cloning and characterization of porcine ribosomal protein L21.
Wu Sheng SUN ; Ju Lan CHUN ; Dong Hwan KIM ; Jin Seop AHN ; Min Kyu KIM ; In Sul HWANG ; Dae Jin KWON ; Seongsoo HWANG ; Jeong Woong LEE
Journal of Veterinary Science 2017;18(4):531-540
Ribosomal protein L21 (RPL21) is a structural component of the 60S subunit of the eukaryotic ribosome. This protein has an important role in protein synthesis and the occurrence of hereditary diseases. Pig is a common laboratory model, however, to the best of our knowledge, its RPL21 gene has not been cloned to date. In this study, we cloned and identified the full-length sequence of the pig RPL21 gene for the first time. In addition, we examined its expression pattern and function by using overexpression or knockdown approaches. As a result, we obtained a 604 bp segment that contains a 483 bp open reading frame encoding 160 amino acids. The pig RPL21 gene is located in the “+” strand of chromosome 11, which spans 2167 bp from 4199792 to 4201958. Pig RPL21 protein has nine strands and two helices in its secondary structure. Pig RPL21 is predominantly expressed in ovary and lung, at lower levels in kidney, small intestine, and skin, and at the lowest levels in heart and liver. Furthermore, RPL21 expression is closely connected with cell proliferation and cell cycle arrest. The results are intended to provide useful information for the further study of pig RPL21.
Amino Acids
;
Cell Cycle Checkpoints
;
Cell Proliferation
;
Chromosomes, Human, Pair 11
;
Clone Cells
;
Cloning, Molecular*
;
Female
;
Gene Expression
;
Genetic Diseases, Inborn
;
Heart
;
Intestine, Small
;
Kidney
;
Liver
;
Lung
;
Open Reading Frames
;
Ovary
;
Ribosomal Proteins*
;
Ribosomes
;
Skin
;
Sus scrofa
10.Randomized trial of subfascial infusion of ropivacaine for early recovery in laparoscopic colorectal cancer surgery.
Sang Hyun LEE ; Woo Seog SIM ; Go Eun KIM ; Hee Cheol KIM ; Joo Hyun JUN ; Jin Young LEE ; Byung Seop SHIN ; Heejin YOO ; Sin Ho JUNG ; Joungyoun KIM ; Seung Hyeon LEE ; Deok Kyu YO ; Yu Ri NA
Korean Journal of Anesthesiology 2016;69(6):604-613
BACKGROUND: There is a need for investigating the analgesic method as part of early recovery after surgery tailored for laparoscopic colorectal cancer (LCRC) surgery. In this randomized trial, we aimed to investigate the analgesic efficacy of an inverse ‘v’ shaped bilateral, subfascial ropivacaine continuous infusion in LCRC surgery. METHODS: Forty two patients undergoing elective LCRC surgery were randomly allocated to one of two groups to receive either 0.5% ropivacaine continuous infusion at the subfascial plane (n = 20, R group) or fentanyl intravenous patient controlled analgesia (IV PCA) (n = 22, F group) for postoperative 72 hours. The primary endpoint was the visual analogue scores (VAS) when coughing at postoperative 24 hours. Secondary end points were the VAS at 1, 6, 48, and 72 hours, time to first flatus, time to first rescue meperidine requirement, rescue meperidine consumption, length of hospital stay, postoperative nausea and vomiting, sedation, hypotension, dizziness, headache, and wound complications. RESULTS: The VAS at rest and when coughing were similar between the groups throughout the study. The time to first gas passage and time to first rescue meperidine at ward were significantly shorter in the R group compared to the F group (P = 0.010). Rescue meperidine was administered less in the R group; however, without statistical significance. Other study parameters were not different between the groups. CONCLUSIONS: Ropivacaine continuous infusion with an inverse ‘v ’ shaped bilateral, subfascial catheter placement showed significantly enhanced bowel recovery and analgesic efficacy was not different from IV PCA in LCRC surgery.
Analgesia
;
Analgesia, Patient-Controlled
;
Anesthetics, Local
;
Catheters
;
Colorectal Neoplasms*
;
Colorectal Surgery
;
Cough
;
Dizziness
;
Fentanyl
;
Flatulence
;
Headache
;
Humans
;
Hypotension
;
Laparoscopy
;
Length of Stay
;
Meperidine
;
Methods
;
Passive Cutaneous Anaphylaxis
;
Postoperative Nausea and Vomiting
;
Wounds and Injuries

Result Analysis
Print
Save
E-mail